Cited by 780Parkinson's Disease Mechanisms and TreatmentsCoffee research and impactsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Association of Coffee and Caffeine Intake With the Risk of Parkinson Disease

Ross, G. Webster·2000·JAMA

DOI 10.1001/jama.283.20.2674

Open this paper in CoChat — free account

Abstract

CONTEXT: The projected expansion in the next several decades of the elderly population at highest risk for Parkinson disease (PD) makes identification of factors that promote or prevent the disease an important goal. OBJECTIVE: To explore the association of coffee and dietary caffeine intake with risk of PD. DESIGN, SETTING, AND PARTICIPANTS: Data were analyzed from 30 years of follow-up of 8004 Japanese-American men (aged 45-68 years) enrolled in the prospective longitudinal Honolulu Heart Program between 1965 and 1968. MAIN OUTCOME MEASURE: Incident PD, by amount of coffee intake (measured at study enrollment and 6-year follow-up) and by total dietary caffeine intake (measured at enrollment). RESULTS: During follow-up, 102 men were identified as having PD. Age-adjusted incidence of PD declined consistently with increased amounts of coffee intake, from 10.4 per 10,000 person-years in men who drank no coffee to 1.9 per 10,000 person-years in men who drank at least 28 oz/d (P<.001 for trend). Similar relationships were observed with total caffeine intake (P<.001 for trend) and caffeine from non-coffee sources (P=.03 for trend). Consumption of increasing amounts of coffee was also associated with lower risk of PD in men who were never, past, and current smokers at baseline (P=.049, P=.22, and P=.02, respectively, for trend). Other nutrients in coffee, including niacin, were unrelated to PD incidence. The relationship between caffeine and PD was unaltered by intake of milk and sugar. CONCLUSIONS: Our findings indicate that higher coffee and caffeine intake is associated with a significantly lower incidence of PD. This effect appears to be independent of smoking. The data suggest that the mechanism is related to caffeine intake and not to other nutrients contained in coffee. JAMA. 2000;283:2674-2679.

Integrity signals

Registry

Crossref · 10.1001/jama.283.20.2674

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Parkinson's Disease
Lang, A. E., & Lozano, A. M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810083391506 · Cited by 2,072
Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects
Nehlig, A., Daval, J., & Debry, G. (1992) · Brain Research Reviews · doi:10.1016/0165-0173(92)90012-b · Cited by 1,463
Parkinson Disease in Twins
Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R. P., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 876
Epidemiology of parkinson’s disease
Tanner, C. M., & Goldman, S. M. (1996) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70259-0 · Cited by 640
Coffee, Alcohol and Risk of Coronary Heart Disease among Japanese Men Living in Hawaii
Yano, K., Rhoads, G. G., & Kagan, A. (1977) · New England Journal of Medicine · doi:10.1056/nejm197708252970801 · Cited by 524
Prevalence of Dementia in Older Japanese-American Men in Hawaii: The Honolulu-Asia Aging Study
White, L. (1996) · JAMA · doi:10.1001/jama.1996.03540120033030 · Cited by 437
TEN-YEAR INCIDENCE OF CORONARY HEART DISEASE IN THE HONOLULU HEART PROGRAM
Yano, K., REED, D. M., & McGee, D. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113787 · Cited by 370
Worldwide Occurrence of Parkinson's Disease: An Updated Review
Zhang, Z., & Román, G. C. (1993) · Neuroepidemiology · doi:10.1159/000110318 · Cited by 332

Show all 35 references

Sorted by citations

Items 201–300 of 780

Role of Microglia Adenosine A2AReceptors in Retinal and Brain Neurodegenerative Diseases
Santiago, A. R., Baptista, F. I., Santos, P. F., Cristóvão, G., Ambrósio, A. F., Cunha, R. A., & Gomes, C. A. (2014) · Mediators of Inflammation · doi:10.1155/2014/465694 · Cited by 81
Caffeine induces sustained apoptosis of human gastric cancer cells by activating the caspase-9/caspase-3 signalling pathway
Liu, H., Zhou, Y., & Tang, L. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6894 · Cited by 78
Dorsal Striatum Dopamine Levels Fluctuate Across the Sleep–Wake Cycle and Respond to Salient Stimuli in Mice
Dong, H., Wang, J., Yang, Y., Shen, Y., Qu, W., & Huang, Z. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00242 · Cited by 75
Intake of Japanese and Chinese teas reduces risk of Parkinson’s disease
Tanaka, K., Miyake, Y., Fukushima, W., Sasaki, S., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., Miki, T., Kawamura, N., et al. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.02.016 · Cited by 77
Relationship between Blood Levels of Heavy Metals and Parkinson’s Disease in China
Fukushima, T., Tan, X., Luo, Y., & Kanda, H. (2009) · Neuroepidemiology · doi:10.1159/000255462 · Cited by 75
Caffeine extends life span, improves healthspan, and delays age-associated pathology in Caenorhabditis elegans
Sutphin, G. L., Bishop, E., Yanos, M. E., Moller, R. M., & Kaeberlein, M. R. (2012) · Longevity & Healthspan · doi:10.1186/2046-2395-1-9 · Cited by 76
Beneficial Effects of Epigallocatechin-3-O-Gallate, Chlorogenic Acid, Resveratrol, and Curcumin on Neurodegenerative Diseases
Fukutomi, R., Ohishi, T., Koyama, Y., Pervin, M., Nakamura, Y., & Isemura, M. (2021) · Molecules · doi:10.3390/molecules26020415 · Cited by 78
Neuroprotection comparison of chlorogenic acid and its metabolites against mechanistically distinct cell death-inducing agents in cultured cerebellar granule neurons
Taram, F., Winter, A. N., & Linseman, D. A. (2016) · Brain Research · doi:10.1016/j.brainres.2016.07.028 · Cited by 73
Bowel movement frequency in late‐life and substantia nigra neuron density at death
Petrovitch, H., Abbott, R. D., Ross, G. W., Nelson, J. R., Masaki, K., Tanner, C. M., Launer, L. J., & White, L. R. (2008) · Movement Disorders · doi:10.1002/mds.22360 · Cited by 72
Self-citation
Dietary patterns and risk of Parkinson’s disease: a case–control study in Japan
Okubo, H., Miyake, Y., Sasaki, S., Murakami, K., Tanaka, K., Fukushima, W., Kiyohara, C., Tsuboi, Y., Yamada, T., Oeda, T., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03600.x · Cited by 71
2-Furoylglycine as a Candidate Biomarker of Coffee Consumption
Heinzmann, S. S., Holmes, E. C., Kochhar, S., Nicholson, J. K., & Schmitt‐Kopplin, P. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b03040 · Cited by 71
Effects of Paraxanthine and Caffeine on Sleep, Locomotor Activity, and Body Temperature in Orexin/Ataxin-3 Transgenic Narcoleptic Mice
Okuro, M., Fujiki, N., Kotorii, N., Ishimaru, Y., Sokoloff, P., & Nishino, S. (2010) · SLEEP · doi:10.1093/sleep/33.7.930 · Cited by 70
Evaluation of distribution of adenosine A2A receptors in normal human brain measured with [11C]TMSX PET
Mishina, M., Ishiwata, K., Kimura, Y., Naganawa, M., Oda, K., Kobayashi, S., Katayama, Y., & Ishii, K. (2007) · Synapse · doi:10.1002/syn.20423 · Cited by 71
Parkinson’s disease updates: Addressing the pathophysiology, risk factors, genetics, diagnosis, along with the medical and surgical treatment
Prajjwal, P., Sanga, H. S. F., Acharya, K., Tango, T., John, J., Rodriguez, R. S. C., Marsool, M. D. M., Sulaimanov, M., Ahmed, A., & Hussin, O. A. (2023) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000001142 · Cited by 88
Meeting Report: Consensus Statement—Parkinson’s Disease and the Environment: Collaborative on Health and the Environment and Parkinson’s Action Network (CHE PAN) Conference 26–28 June 2007
Bronstein, J. M., Carvey, P. M., Chen, H., Cory‐Slechta, D. A., Monte, D. A. D., Duda, J. E., English, P. B., Goldman, S. M., Grate, S. J., Hansen, J., et al. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11702 · Cited by 75
Self-citation
Dopaminergic effects of caffeine in the human striatum and thalamus
Kaasinen, V., Aalto, S., Någren, K., & Rinne, J. O. (2004) · Neuroreport · doi:10.1097/00001756-200402090-00014 · Cited by 66
Decaffeinated coffee prevents scopolamine-induced memory impairment in rats
Jang, Y. J., Kim, J., Shim, J., Kim, C., Jang, J.-H., Lee, K. W., & Lee, H. J. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.02.003 · Cited by 69
Oral caffeine administration ameliorates acute colitis by suppressing chitinase 3-like 1 expression in intestinal epithelial cells
Lee, I., Low, D., Kamba, A., Lladó, V., & Mizoguchi, E. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0865-3 · Cited by 67
Neuroprotection in Parkinson’s disease: facts and hopes
Salamon, A., Zádori, D., Szpisjak, L., Klivènyi, P., & Vécsei, L. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02115-8 · Cited by 67
Protective effect of caffeine against neurodegeneration in a model of Parkinson's disease in rat: behavioral and histochemical evidence
Joghataei, M. T., Roghani, M., Negahdar, F., & Hashemi, L. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.06.004 · Cited by 69
Role of Secondary Mediators in Caffeine-Mediated Neuroprotection in Maneb- and Paraquat-Induced Parkinson’s Disease Phenotype in the Mouse
Yadav, S., Gupta, S. P., Srivastava, G., Srivastava, P. K., & Singh, M. P. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0682-0 · Cited by 69
The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson’s Disease
Mori, A., Chen, J., Uchida, S., Durlach, C., King, S. M., & Jenner, P. G. (2022) · Molecules · doi:10.3390/molecules27072366 · Cited by 67
Autotoxicity, methylation and a road to the prevention of Parkinson’s disease
Williams, A. C., & Ramsden, D. B. (2004) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2004.10.002 · Cited by 65
Caffeine alters proliferation of neuronal precursors in the adult hippocampus
Wentz, C. T., & Magavi, S. S. P. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.02.002 · Cited by 65
What and How Can Physical Activity Prevention Function on Parkinson’s Disease?
Fan, B., Jabeen, R., Bo, B., Guo, C., Meng-jie, H., Zhang, H., Cen, J., Ji, X., & Wei, J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4293071 · Cited by 66
Update on epidemiological aspects of progressive supranuclear palsy
Litvan, I. (2003) · Movement Disorders · doi:10.1002/mds.10562 · Cited by 64
Automated methods for diagnosis of Parkinson’s disease and predicting severity level
Ayaz, Z., Naz, S., Khan, N. H., Razzak, I., & Imran, M. A. (2022) · Neural Computing and Applications · doi:10.1007/s00521-021-06626-y · Cited by 68
Can coffee consumption lower the risk of Alzheimer’s disease and Parkinson’s disease? A literature review
Wierzejska, R. E. (2017) · Archives of Medical Science · doi:10.5114/aoms.2016.63599 · Cited by 63
Potentiation of cannabinoid signaling in microglia by adenosine A2A receptor antagonists
Franco, R., Reyes‐Resina, I., Aguinaga, D., Lillo, A., Jiménez, J., Raïch, I., Borroto‐Escuela, D. O., Ferreiro‐Vera, C., Canela, E. I., de Medina, V. S., et al. (2019) · Glia · doi:10.1002/glia.23694 · Cited by 60
Adenosine A2A Antagonists in Parkinson’s Disease: What’s Next?
Hickey, P., & Stacy, M. A. (2012) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-012-0279-2 · Cited by 64
Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions
Machado-Filho, J. A., Correia, A. O., Montenegro, A. B. A., Nobre, M. E. P., Cerqueira, G. S., Neves, K. R. T., Naffah‐Mazzacoratti, M. D. G., Cavalheiro, É. A., Brito, G. A. D. C., & Viana, G. S. D. B. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.01.051 · Cited by 61
Nicotinamide: A double edged sword
Williams, A. C., & Ramsden, D. B. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.05.011 · Cited by 61
Differential regulation of microglial motility by ATP/ADP and adenosine
Gyoneva, S., Orr, A. G., & Traynelis, S. F. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70813-2 · Cited by 64
A Comprehensive Overview of the Risks and Benefits of Coffee Consumption
Pourshahidi, L. K., Navarini, L., Petracco, M., & Strain, J. (2016) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12206 · Cited by 64
Adenosine A2A Receptor Antagonists in Neurodegenerative Diseases: Huge Potential and Huge Challenges
Franco, R., & Navarro, G. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00068 · Cited by 60
Macronutrients, aluminium from drinking water and foods, and other metals in cognitive decline and dementia
Solfrizzi, V., Colacicco, A. M., D’Introno, A., Capurso, C. A., Parigi, A. D., Capurso, S. A., Torres, F., Capurso, A., & Panza, F. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-102-314 · Cited by 59
Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease
Siderowf, A. D., Jennings, D. L., Connolly, J., Doty, R. L., MAREK, K. L., & Stern, M. B. (2007) · Movement Disorders · doi:10.1002/mds.21707 · Cited by 62
Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review
Bansal, R., & Singh, R. (2017) · Medicinal Research Reviews · doi:10.1002/med.21458 · Cited by 62
Adenosine A2A Receptor Antagonists for Parkinson???s Disease
Hauser, R. A., & Schwarzschild, M. A. (2005) · Drugs & Aging · doi:10.2165/00002512-200522060-00002 · Cited by 58
Metabolomics and lipidomics strategies in modern drug discovery and development
Astarita, G., Kelly, R. S., & Lasky-Su, J. A. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103751 · Cited by 63
Effects of chronic caffeine intake in a mouse model of amyotrophic lateral sclerosis
Potenza, R. L., Armida, M., Ferrante, A., Pèzzola, A., Matteucci, A., Puopolo, M., & Popoli, P. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23185 · Cited by 57
Variation in the human lipidome associated with coffee consumption as revealed by quantitative targeted metabolomics
Altmaier, E., Kastenmüller, G., Römisch‐Margl, W., Thorand, B., Weinberger, K. M., Adamski, J., Illig, T., Döring, A., & Suhre, K. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900116 · Cited by 57
Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriers
Crotty, G. F., Maciuca, R. D., Macklin, E. A., Wang, J., Montalban, M., Davis, S. S., Alkabsh, J. I., Bakshi, R., Chen, X., Ascherio, A., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000010863 · Cited by 58
Elucidating the Neuroprotective Role of PPARs in Parkinson’s Disease: A Neoteric and Prospective Target
Behl, T., Madaan, P., Sehgal, A., Singh, S., Sharma, N., Bhatia, S., Al‐Harrasi, A., Chigurupati, S., Alrashdi, I., & BUNGAU, S. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810161 · Cited by 58
Coffee and Amyotrophic Lateral Sclerosis: A Possible Preventive Role
Beghi, E., Pupillo, E., Messina, P., Giussani, G., Chiò, A., Zoccolella, S., Moglia, C., Corbo, M., & Logroscino, G. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr229 · Cited by 57
Uncovering multiple molecular targets for caffeine using a drug target validation strategy combining A2Areceptor knockout mice with microarray profiling
Yu, L., Coelho, J. E., Zhang, X., Fu, Y., Tillman, A., Karaöz, U., Fredholm, B. B., Weng, Z., & Chen, J. (2009) · Physiological Genomics · doi:10.1152/physiolgenomics.90353.2008 · Cited by 58
Diet, Microbiota and Brain Health: Unraveling the Network Intersecting Metabolism and Neurodegeneration
Gentile, F., Doneddu, P. E., Riva, N., Nobile‐Orazio, E., & Quattrini, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207471 · Cited by 58
Caffeine Protects Dopaminergic Neurons From Dopamine-Induced Neurodegeneration via Synergistic Adenosine-Dopamine D2-Like Receptor Interactions in Transgenic Caenorhabditis Elegans
Manalo, R. V. M., & Medina, P. M. B. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00137 · Cited by 55
Parkinson's Disease: Risk Factor Modification and Prevention
Rajan, S. M., & Kaas, B. M. (2022) · Seminars in Neurology · doi:10.1055/s-0042-1758780 · Cited by 58
Parkinson's Disease: Mitochondrial Molecular Pathology, Inflammation, Statins, and Therapeutic Neuroprotective Nutrition
KONES, R. J. (2010) · Nutrition in Clinical Practice · doi:10.1177/0884533610373932 · Cited by 57
Caffeine, mood and mental performance in everyday life
Rogers, P. J. (2007) · Nutrition Bulletin · doi:10.1111/j.1467-3010.2007.00607.x · Cited by 58
Effets des nutriments sur les structures et les fonctions du cerveau : le point sur la diététique du cerveau
Bourre, J. M. (2004) · Revue Neurologique · doi:10.1016/s0035-3787(04)71032-2 · Cited by 57
Amyotrophic lateral sclerosis and food intake
Pupillo, E., Bianchi, E., Chiò, A., Casale, F., Zecca, C., Tortelli, R., Beghi, E., Slalom, F., Parals, & Groups, A. F. S. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1418002 · Cited by 54
Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives
Deb, P. K., Deka, S., Borah, P., Abed, S. N., & Klotz, K. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190716100509 · Cited by 54
Brain imaging and the effects of caffeine and nicotine
Dager, S., & Friedman, S. (2000) · Annals medicus · doi:10.3109/07853890009002029 · Cited by 53
Lack of tolerance to motor stimulant effects of a selective adenosine A2A receptor antagonist
Halldner, L., Lozza, G., Lindström, K., & Fredholm, B. B. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00682-8 · Cited by 52
Effects of Enteric Environmental Modification by Coffee Components on Neurodegeneration in Rotenone-Treated Mice
Miyazaki, I., Isooka, N., Wada, K., Kikuoka, R., Kitamura, Y., & Asanuma, M. (2019) · Cells · doi:10.3390/cells8030221 · Cited by 53
The use of nanopore analysis for discovering drugs which bind to α-synuclein for treatment of Parkinson's disease
Tavassoly, O., Kakish, J., Nokhrin, S. M., Dmitriev, O. Y., & Lee, J. S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.07.090 · Cited by 55
Cytoprotective effect of chlorogenic acid against α-synuclein-related toxicity in catecholaminergic PC12 cells
Teraoka, M., Nakaso, K., Kusumoto, C., Katano, S., Tajima, N., Yamashita, A., Zushi, T., Ito, S., & Matsura, T. (2012) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.d-11-00030 · Cited by 53
Caffeine in Parkinson's disease: A pilot open‐label, dose‐escalation study
Altman, R., Lang, A. E., & Postuma, R. B. (2011) · Movement Disorders · doi:10.1002/mds.23873 · Cited by 55
Parkinson's disease: the first common neurological disease due to auto-intoxication?
Williams, A. C., Cartwright, L. S., & Ramsden, D. B. (2005) · QJM · doi:10.1093/qjmed/hci027 · Cited by 53
Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson's disease in men and women
Palacios, N., Weisskopf, M. G., Simon, K., Gao, X., Schwarzschild, M. A., & Ascherio, A. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.02.012 · Cited by 51
Nutritional habits, risk, and progression of Parkinson disease
Erro, R., Brigo, F., Tamburin, S., Zamboni, M. M., Antonini, A., & Tinazzi, M. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8639-0 · Cited by 56
Cafeína: un nutriente, un fármaco, o una droga de abuso
Lozano, R. P., García, Y. Á., Barral, D., & Farré, M. (2007) · Adicciones · doi:10.20882/adicciones.303 · Cited by 51
Increases in Cerebrospinal Fluid Caffeine Concentration are Associated with Favorable Outcome after Severe Traumatic Brain injury in Humans
Sachse, K. T., Jackson, E. K., Wisniewski, S. R., Gillespie, D. G., Puccio, A. M., Clark, R. S. B., Dixon, C. E., & Kochanek, P. M. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600539 · Cited by 50
The role of ATP and adenosine in the brain under normoxic and ischemic conditions
Pedata, F., Melani, A., Pugliese, A. M., Coppi, E., Cipriani, S., & Traini, C. (2007) · Purinergic Signalling · doi:10.1007/s11302-007-9085-8 · Cited by 51
Neuroprotective effects of caffeine in MPTP model of Parkinson's disease: A 13 C NMR study
Bagga, P., Chugani, A. N., & Patel, A. B. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.11.006 · Cited by 50
Caffeine may enhance orthodontic tooth movement through increasing osteoclastogenesis induced by periodontal ligament cells under compression
Yi, J., Yan, B., Li, M., Wang, Y., Zheng, W., Li, Y., & Zhao, Z. (2016) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2015.12.009 · Cited by 49
Novel Players in the Aging Synapse: Impact on Cognition
Temido‐Ferreira, M., Coelho, J. E., Pousinha, P. A., & Lopes, L. V. (2019) · Journal of Caffeine and Adenosine Research · doi:10.1089/caff.2019.0013 · Cited by 57
The Human D2 Dopamine Receptor Synergizes with the A2A Adenosine Receptor to Stimulate Adenylyl Cyclase in PC12 Cells
Kudlacek, O., Just, H., Korkhov, V. M., Vartian, N., Klinger, M., Pankevych, H., Yang, Q., Nanoff, C., Freissmuth, M., & Boehm, S. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300181 · Cited by 50
Cardiovascular Effects of Coffee: Is It a Risk Factor?
Sudano, I., Binggeli, C., Spieker, L. E., Lüscher, T. F., Ruschitzka, F. T., Noll, G., & Corti, R. (2005) · Progress in Cardiovascular Nursing · doi:10.1111/j.0889-7204.2005.02477.x · Cited by 48
Herbal Medicines in Pregnancy and Lactation: An Evidence-Based Approach
Mills, E. J., Duguoa, J.-J., Perri, D., & Koren, G. (2006) · Cited by 50
Microglial Adenosine Receptors: From Preconditioning to Modulating the M1/M2 Balance in Activated Cells
Franco, R., Lillo, A., Rivas‐Santisteban, R., Reyes‐Resina, I., & Navarro, G. (2021) · Cells · doi:10.3390/cells10051124 · Cited by 51
Understanding the effect of smoking and drinking behavior on Parkinson's disease risk: a Mendelian randomization study
Domínguez-Baleón, C., Ong, J., Scherzer, C. R., Rentería, M. E., & Dong, X. (2021) · Scientific Reports · doi:10.1038/s41598-021-93105-y · Cited by 49
Modulators of Nucleoside Metabolism in the Therapy of Brain Diseases
Boison, D. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795347609 · Cited by 51
Caffeine and a selective adenosine A2A receptor antagonist induce sensitization and cross-sensitization behavior associated with increased striatal dopamine in mice
Hsu, C. W., Wang, C. S., & Chiu, T. H. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-4 · Cited by 49
Neurodegenerative Diseases: Can Caffeine Be a Powerful Ally to Weaken Neuroinflammation?
Ruggiero, M., Calvello, R., Porro, C., Messina, G., Cianciulli, A., & Panaro, M. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112958 · Cited by 59
Available and emerging treatments for Parkinson’s disease: a review
Stacy, M. A., Hickey, P., & Stacy, M. A. (2011) · Drug Design Development and Therapy · doi:10.2147/dddt.s11836 · Cited by 51
Parkinson's disease: 10 years of progress, 1997–2007
Fahn, S. (2010) · Movement Disorders · doi:10.1002/mds.22796 · Cited by 51
Gene-Environment Interaction in Parkinson's Disease: Coffee, ADORA2A, and CYP1A2
Chuang, Y., Lill, C. M., Lee, P., Hansen, J., Lassen, C. F., Bertram, L., Greene, N., Sinsheimer, J. S., & Ritz, B. R. (2016) · Neuroepidemiology · doi:10.1159/000450855 · Cited by 49
An exploratory analysis on gene-environment interactions for Parkinson disease
Gao, J., Nalls, M. A., Shi, M., Joubert, B. R., Hernandez, D. G., Huang, X., Hollenbeck, A. R., Singleton, A., & Chen, H. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.007 · Cited by 50
Higher Coffee Consumption Is Associated With Slower Cognitive Decline and Less Cerebral Aβ-Amyloid Accumulation Over 126 Months: Data From the Australian Imaging, Biomarkers, and Lifestyle Study
Gardener, S. L., Rainey‐Smith, S. R., Villemagne, V. L., Fripp, J., Doré, V., Bourgeat, P., Taddei, K., Fowler, C. J., Masters, C. L., Maruff, P. T., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.744872 · Cited by 53
Intakes of caffeine, coffee and tea and risk of amyotrophic lateral sclerosis: Results from five cohort studies
Fondell, E., O’Reilly, É. J., Fitzgerald, K. C., Falcone, G. J., Kolonel, L. N., Park, Y., Gapstur, S. M., & Ascherio, A. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1020813 · Cited by 47
The Benefit of Bone Health by Drinking Coffee among Korean Postmenopausal Women: A Cross-Sectional Analysis of the Fourth & Fifth Korea National Health and Nutrition Examination Surveys
Choi, E., Choi, K.-H., Park, S. M., Shin, D., Joh, H., & Cho, E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147762 · Cited by 46
Caffeinated clues from epidemiology of Parkinson’s disease
Ascherio, A., & Chen, H. (2003) · Neurology · doi:10.1212/01.wnl.0000095213.86899.21 · Cited by 47
Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson’s Disease
Schepici, G., Silvestro, S., Bramanti, P., & Mazzon, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134766 · Cited by 48
Polyphenols and Flavonoids in Controlling Non-Alcoholic Steatohepatitis
Jadeja, R. N., & Devkar, R. V. (2013) · Polyphenols in Human Health and Disease · doi:10.1016/b978-0-12-398456-2.00047-5 · Cited by 45
Neuroprotection in Parkinson's disease
Schapira, A. H. V. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70834-x · Cited by 46
Premotor Parkinson's disease: Clinical features and detection strategies
Stephenson, R., Siderowf, A. D., & Stern, M. B. (2009) · Movement Disorders · doi:10.1002/mds.22403 · Cited by 45
Does a vegan diet reduce risk for Parkinson’s disease?
McCarty, M. F. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1321 · Cited by 45
A systematic review of nutritional risk factors of Parkinson's disease
Ishihara, L., & Brayne, C. (2005) · Nutrition Research Reviews · doi:10.1079/nrr2005108 · Cited by 45
Association of Coffee Consumption and Prediagnostic Caffeine Metabolites With Incident Parkinson Disease in a Population-Based Cohort
Zhao, Y., Lai, Y., Konijnenberg, H., Huerta, J. M., Vinagre‐Aragón, A., Sabin, J., Hansen, J., Petrova, D., Sacerdote, C., Zamora‐Ros, R., et al. (2024) · Neurology · doi:10.1212/wnl.0000000000209201 · Cited by 49
Chlorogenic Acid and Coffee Prevent Hypoxia-Induced Retinal Degeneration
Jang, H., Ahn, H. R., Jo, H., Kim, K., Lee, E. H., Lee, K. W., Jung, S. H., & Lee, C. Y. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf404285v · Cited by 45
Adenosine A2AReceptors in Bone Marrow-Derived Cells But Not in Forebrain Neurons Are Important Contributors to 3-Nitropropionic Acid-Induced Striatal Damage as Revealed by Cell-Type-Selective Inactivation
Huang, Q., Wei, C. J., Yu, L., Coelho, J. E., Shen, H., Kalda, A., Linden, J. M., & Chen, J. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1907-06.2006 · Cited by 44
The Management of Parkinson’s Disease: An Overview of the Current Advancements in Drug Delivery Systems
Nakmode, D. D., Day, C. M., Song, Y., & Garg, S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051503 · Cited by 48
The Janus face of caffeine
Porciúncula, L. O., Sallaberry, C., Mioranzza, S., Botton, P. H. S., & Rosemberg, D. B. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.09.009 · Cited by 45
Attenuated neural response to gamble outcomes in drug-naive patients with Parkinson’s disease
van der Vegt, J. P. M., Hulme, O. J., Zittel, S., Madsen, K. H., Weiß, M., Buhmann, C., Bloem, B. R., Münchau, A. M., & Siebner, H. R. (2013) · Brain · doi:10.1093/brain/awt027 · Cited by 44
Biochemical and Pharmacological Role of A1 Adenosine Receptors and Their Modulation as Novel Therapeutic Strategy
Varani, K., Vincenzi, F., Merighi, S., Gessi, S., & Borea, P. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2017_61 · Cited by 43
Targeting Adenosine Signaling in Parkinson's Disease: From Pharmacological to Non-pharmacological Approaches
Nazario, L. R., da Silva, R. S., & Bonan, C. D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00658 · Cited by 43
The Impact of Coffee and Caffeine on Multiple Sclerosis Compared to Other Neurodegenerative Diseases
Herden, L., & Weissert, R. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00133 · Cited by 46

Authors: Ross, G. W.
Affiliations: United States Department of Veterans Affairs (US)
Corresponding author: Ross, G. Webster
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2000-05-24
Volume: 283
Issue: 20
Pages: 2674
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.283.20.2674
OpenAlex: W2128822428
Cited by: 778
References: 35
Citations by year: 2026: 8 · 2025: 24 · 2024: 28 · 2023: 34 · 2022: 22 · 2021: 39 · 2020: 26 · 2019: 35 · 2018: 26 · 2017: 36 · 2016: 24 · 2015: 29 · 2014: 39 · 2013: 37 · 2012: 36
FWCI: 17.73
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (n01hc005102-027, DAMD17-98-1-8621)
National Institute on Aging (N01‐AG‐4‐2149)
National Heart, Lung, and Blood Institute (N01 HC 05102, NO1-HC-05102)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Parkinson's disease, coffee consumption, dietary caffeine, caffeine consumption, smoking, nicotinic acid, Honolulu Heart Program, Japanese-American men, disease incidence
MeSH terms: Aged, Caffeine, Coffee, Diet Surveys, Humans, Longitudinal Studies, Male, Middle Aged, Parkinson Disease, Regression Analysis, Risk Factors, Incidence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Association of Coffee and Caffeine Intake With the Risk of Parkinson Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks